Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Firebrick Pharma Limited ( (AU:FRE) ) has issued an announcement.
Firebrick Pharma Limited has lodged an application with the ASX for quotation of 21,276,603 new ordinary fully paid shares, to be issued and quoted from April 13, 2026. The enlarged pool of quoted securities, arising from previously flagged transactions, will expand the company’s listed equity base and may enhance trading liquidity and capital flexibility for existing and prospective shareholders.
More about Firebrick Pharma Limited
Firebrick Pharma Limited is an Australia-listed pharmaceutical company trading on the ASX under the code FRE. The company operates in the healthcare and life sciences sector, focusing on the development and commercialisation of pharmaceutical products, with its shares listed as ordinary fully paid securities for public investors.
Average Trading Volume: 89,392
Technical Sentiment Signal: Sell
Current Market Cap: A$14.39M
Find detailed analytics on FRE stock on TipRanks’ Stock Analysis page.